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Abstract
Background: With nearly 15 million annual preterm births globally, preterm birth is the most common cause
of neonatal death. Forty to 60 % of neonatal deaths are directly or indirectly associated with preterm mortality.
As countries aim to meet the Sustainable Development Goals to reduce neonatal mortality, significant reductions in
preterm mortality are needed. This study aims to identify the common causes of preterm illness and their contribution
to preterm mortality in low-resource settings. This article will describe the methods used to undertake the study.
Methods: This is a prospective, multi-centre, descriptive clinical study. Socio-demographic, obstetric, and maternal
factors, and clinical and laboratory findings will be documented. The major causes of preterm mortality will be
identified using clinical, laboratory, imaging, and autopsy methods and use the national Ethiopian guidelines on
management of preterm infants including required investigations to reach final diagnoses. The study will document
the clinical and management protocols followed in these settings. The approach consists of clinical examinations and
monitoring, laboratory investigations, and determination of primary and contributory causes of mortality through both
clinical means and by post-mortem examinations. An independent panel of experts will validate the primary and
contributory causes of mortality.
To obtain the estimated sample size of 5000 preterm births, the study will be undertaken in five hospitals in
three regions of Ethiopia, which are geographically distributed across the country. All preterm infants who are
either born or transferred to these hospitals will be eligible for the study. Three methods (last menstrual
period, physical examination using the New Ballard Score, and ultrasound) will be used to determine
gestational age.
All clinical procedures will be conducted per hospital protocol and informed consent will be taken from parents or
caretakers prior to their participation in the study as well as for autopsy if the infant dies.
Discussion: This study will determine the major causes of death and illness among hospitalized preterm infants in a
low-resource setting. The result will inform policy makers and implementers of areas that can be prioritized in order to
contribute to a significant reduction in neonatal mortality.
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Plain English summary
When babies are born early, or preterm, they may develop
conditions that place them at higher risk for short-term
health problems, long-term neurological complications and
even death. In the United States and other high-income
countries, most infants born preterm now survive, but in
the poorest regions of the world, babies who are born pre-
term are at very high risk of death; in the first month of life
up to half may die. To date, few studies have examined the
specific conditions that lead to deaths among preterm ba-
bies in low-income countries. In this paper, we describe an
approach that will be used for a study about the reasons
why preterm babies cared for in 5 hospitals in Ethiopia die.
After consent, we will collect extensive information about
all preterm babies cared for in the hospital including infor-
mation on the care given during pregnancy, labor and de-
livery as well as for the baby at the hospital. For those
babies who die, additional information, including testing
for infections and with permission, examination of the
body after death will also be done. A group of experts will
then evaluate all the information collected to determine
the final cause of the baby’s death. This information will
help plan future interventions to reduce deaths among
preterm infants.
Background
National estimates of preterm birth (defined as childbirth at
less than 37 completed weeks) for 184 countries have been
published for the year 2010 [1] showing nearly 15 million
preterm births. In the Global Burden of Disease Study,
3.1% of all disability-adjusted life-years was attributed to
preterm birth, similar to the burden of HIV or malaria [2].
Globally, the estimated preterm birth rate is 11.1%. Over
60% of preterm births occur in sub-Saharan Africa and
South Asia (1). Ethiopia is among the top 15 countries that
contribute to two-thirds of the world’s preterm babies with
an estimated preterm birth rate of 14.1% [3]. In 2015, 5.9
million children under the age of five died across the globe.
Of these, 44% or 2.6 million deaths occurred within the first
month of life. Just over a third of these babies died as a re-
sult of prematurity-related causes [4].
Evidence from both developed and developing countries
that maintain good birth registries shows that the burden
of preterm birth is increasing [5–11]. Factors possibly con-
tributing to, but not completely explaining this upward
trend, include increasing rates of multiple births, greater
use of assisted reproduction techniques, increases in the
proportion of births among women over 34 years of age
and changes in clinical practices, such as greater use of
labour induction and elective Caesarean section.
Preterm birth is a major determinant of neonatal mortal-
ity and morbidity and has long-term adverse consequences
for health [12]. Complications from preterm births are the
leading direct cause of neonatal deaths accounting for 35%
of all newborn deaths, and are also a contributing cause in
an additional 40 to 60% of neonatal deaths. Mortality rates
increase proportionally with decreasing gestational age or
birth weight [13–16]. In Ethiopia, of the estimated 91,700
neonatal deaths in 2010, more than one-third were esti-
mated to be due to complications of preterm birth [17].
In the 1990’s, 70% of 11.6 million under-five deaths were
due to a handful of conditions, i.e., acute respiratory infec-
tions (mostly pneumonia), diarrhoea, measles, malaria, and
malnutrition and often to a combination of these condi-
tions [18, 19]. Neonatal causes were bundled as one cause.
An integrated package of interventions addressing these
conditions developed in 1993 [20] by the World Health
Organization (WHO) contributed to the 51% reduction of
mortality to 5.9 million in 2013 compared to 1993 [21]. By
2013, the major causes of neonatal mortality were further
differentiated to include sepsis and asphyxia; however, pre-
maturity was still recorded as a single cause of neonatal
mortality.
At the time when little or no care was available to man-
age the specific causes of mortality in preterm infants, pre-
maturity was considered as one condition in the global
disease classification nomenclature. As effective inter-
ventions become available for some of the causes of
prematurity-related mortality in low resource settings,
there is a need to determine the distribution of the major
causes of prematurity-related mortality.
In addition to determining the causes of preterm birth, a
better understanding of the sequelae of events leading to
deaths in preterm infants is needed. Similar to term infants,
preterm infants may suffer from multiple morbidities, such
as sepsis, asphyxia, respiratory distress syndrome, major
congenital malformations, and metabolic disorders [22–24].
However, the proportion that each of these condi-
tions contributes to mortality among preterm infants
is not known. The WHO has developed a simplified clin-
ical algorithm [25] to manage sepsis among young infants
below 2 months of age. Even though microbiological stud-
ies for the detection of bacteria or fungi in blood, body
fluids, or relevant tissues continue to be the gold standard
for diagnosis of sepsis, the yield of these cultures is gener-
ally low. Blood cultures were positive in 10% of Ethiopian
young infants with suspected infection in the WHO Young
Infant Study [26]. The diagnosis of respiratory distress syn-
drome (RDS) depends on the clinical presentation of severe
respiratory distress with hypoxaemia, and a reticulo-granu-
lar pattern on a chest x-ray. The challenge is to differentiate
RDS from congenitally-acquired lung infections or perinatal
asphyxia. Preterm infants with intraventricular haem-
orrhage may not manifest any signs or only show
signs of anaemia, increased head circumference, re-
spiratory distress or neurological manifestations such as
seizures. The latter symptoms can also be signs of meta-
bolic disturbances.
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To address the gap in knowledge of mortality and the
morbidity associated with preterm birth, we are under-
taking a prospective study of cause of preterm infant
death in Ethiopia, the Study of Illness in Preterm (SIP)
project.
Objectives
The primary objective of the SIP project is to determine
the most common causes of illness and mortality in pre-
term infants admitted to hospitals in Ethiopia based on a
standardized diagnostic protocol.
Secondary objectives of the study include the following:
1. To determine the proportion of positive blood and
cerebral spinal fluid cultures among preterm infants
with a final diagnosis of sepsis
2. To determine the proportion of radiological findings
consistent with RDS
3. To determine the proportion of head ultrasound
findings consistent with intraventricular
haemorrhage
4. To determine maternal/obstetric risk factors that
are associated with preterm birth as well as
mortality in preterm infants
5. To classify preterm infants based on gestational age
(GA) and birth weight (if known) as extremely
preterm (< 28 weeks) very preterm (28–32 weeks)
preterm (32–37 weeks) in relation to the cause of
death, to understand the GA where most of the
deaths are concentrated and the corresponding
birth weight if known
6. To compare the clinical final diagnosis of preterm
infants that die with the results from the diagnosis
obtained by standard autopsy and Minimally
Invasive Tissue Sampling (MITS)
Methods/design
Study design
The study is a prospective multi-centre descriptive clinical
study. Socio-demographic, obstetric, and maternal factors
will be documented in addition to various methods of esti-
mating gestational age before birth and at or around birth.
Detailed clinical variables as well as laboratory and post-
mortem findings will be recorded in a standardized man-
ner. The major causes of preterm mortality will be
identified using clinical, laboratory, imaging and aut-
opsy methods.
Prior to the study, discussions were held with the clinical
staff at each hospital regarding best practice for a number
of conditions affecting the neonate, but no attempt was
made to use the data collected for this study as part of a
continuous quality improvement program at the study sites.
In the study settings, measures such as exclusive breast
feeding, keeping the baby warm, kangaroo mother care,
resuscitation for perinatal asphyxia, continuous positive air-
way pressure (CPAP) for RDS, antibiotics for sepsis, which
are routinely provided, will be provided for the study pa-
tients per clinical protocols. The study will standardize indi-
cations for investigations so that the main diagnoses can be
determined. In those infants who die, attempts will be made
to obtain consent from parents for a post-mortem
examination.
The study approach will consist of monitoring of clin-
ical progress to understand the sequence of events, basic
investigations and determination of primary and con-
tributory causes of mortality followed by post-mortem
examinations. Finally, an independent panel of experts
will validate the primary and contributory causes of
mortality (Fig. 1). The post-mortem examinations could
be a whole body diagnostic autopsy or MITS method re-
cently described in other countries [27].
The study will aim to carry out post-mortem examina-
tions when consent is obtained from parents for autopsy.
In a previous study in Addis Ababa, almost half of the
bodies of the preterm infants were not collected by par-
ents and this practice may facilitate obtaining consent
for autopsy [28].
Study settings
Selection of study sites
The study will be conducted in 3 locations in Ethiopia, with
an intent to obtain geographical representation from several
regions across the country. The main criteria for selection
of hospitals for the study were prior research experience
with newborn care, and the expected number of preterm
infants that could be enrolled per year. Tikur Anbessa Hos-
pital, Ghandi Memorial Hospital and St Paul Hospital in
Addis Ababa, Gondar University Hospital in the north and
Jimma University Hospital in south-west of Ethiopia have
significant child health research experience and the largest
number of newborn intensive care unit (NICU) admissions
in the country.
Study participants
All preterm live-born infants admitted to one of the study
hospitals with a gestational age of less than 37 completed
weeks will be enrolled. The study hospitals admit all pre-
term infants that are alive without any lower limit.
Three methods (last menstrual period [LMP], physical
examination using the Ballard Score, and ultrasound) will
be applied for assessment of gestational age. Ultrasound
(US)-predicted GA is determined by the fetal crown-rump
length if taken in the first trimester and by a combination
of fetal head circumference, abdominal circumference and
femur length for exams performed early in the second tri-
mester. Data on the US examination (if available) will be
collected during admission of the preterm infant from the
hospital records.
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GA assessment is also assessed using the LMP. An accur-
ate record of LMP means that the mother is sure of the
exact date of the LMP and that her pregnancy is confirmed
soon after a missing period; she had regular menstrual pe-
riods prior to conception; and she has not conceived imme-
diately after stopping hormonal contraceptives.
The most widely accepted scoring system for post-
natal estimation of GA is the New Ballard Score [29].
For SIPS, the Ballard examination will be done for all
preterm infants at < 7 days of life by the study doctor
to determine eligibility for the study. The new Ballard
has two components: neuromuscular and physical ma-
turity scoring. The accuracy of the Ballard is gener-
ally considered to be valid within a range of +/− 2
weeks.
For purposes of eligibility enrolment into the SIP study, if
the difference between GA assessed by Ballard and that cal-
culated from an accurate (LMP (as described above) is not
greater than 2 weeks, the LMP GA will be assumed to be
correct; and vice versa if the difference between the two
measurements is greater than 2 weeks.
Screening and enrolment
Three scenarios are possible for patient screening and
enrolment:
1. A woman who has been seen for antenatal care in
the study hospital, goes into preterm labour, and
the infant is born alive at the study hospital or
home.
2. A woman who came in preterm labour to the study
hospital from home or is referred from another
health facility and delivers a live infant
3. A woman who delivered a preterm infant at home
or in another hospital brings her preterm infant to
NICU at < 7 days of life.
In all scenarios, the gestational age is estimated by a
set of criteria as shown below. When preterm birth is
confirmed and the consent is obtained, then the obstet-
ric history and other clinical forms are completed.
Eligibility criteria
All preterm infants admitted to one of the study hospi-
tals with a gestational age of less than 37 completed
weeks and up to the age of 7 days of postnatal life will
be enrolled. Three methods, i.e., ultrasound, LMP and
physical examination using the new Ballard Score will be
used to estimate gestational age and to be sure that an
infant is indeed “preterm”. The following criteria will be
used:
 Mother delivered at or baby transferred to one of
the participating study hospitals;
 Gestational age is < 37 weeks according to the
algorithm with the 3 methods;
 Live born defined as cry, breathing or movement
after delivery or Apgar ≥ 1;
 Infant age is < 7 days when screened; and
 Consent given for study participation.
Any live born baby that meets the gestational age and age
criteria will be enrolled in the study regardless of whether
the baby dies prior to admission to the NICU or is dis-
charged home without admission.
Fig. 1 SIP Study Approaches
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Exclusion criteria
 Delivery is a result of an induced abortion
 Gestational age cannot be reliably determined using
study criteria.
Study outcomes
The primary outcome of the study is determination of
the main causes of mortality of preterm infants in a
low-resource setting. Secondary outcomes include the
determination of common preterm problems, microbio-
logical profile of sepsis in preterm infants, maternal and
obstetric risk factors for preterm mortality and compari-
son of clinical diagnosis against autopsy diagnosis, and
comparison of standard autopsy diagnosis with that from
MITS.
Sample size
The study will take place in five hospitals each with an
average yearly admission of nearly 500 preterm infants
(with an average of 20% mortality rate).The study enrol-
ment will continue for a period of 24 months to provide
data on 4000 to 5000 preterm admissions across the
study sites. Based on baseline data, 1000 preterm deaths
are anticipated. Of those, we anticipate consent and
completion of around 300 autopsies. The SIP sample
size is calculated using the formula to determine sample
size for a proportion:
n ¼ Zα
2
2 P 1−Pð Þ
d2
Where.
n = the minimum sample size required for the study.
P = expected prevalence/proportion.
d = level of precision.
Zα/2 = the standard normal distribution percentile
=1.96 for a 95% level of confidence.
The sample size assumed that 20% of preterm deaths
are due to one of the likely causes of preterm mortality.
With a 4% precision and 95% level of confidence, the
sample size required will be 384preterm deaths with
confirmed cause of mortality. Assuming an attrition of
10 to 20% for potential exclusions and refusal to consent
to post-mortem examinations for about 50% of the
cases, we will need between 770 and 960 preterm deaths.
With a case fatality rate of preterm admissions of 20 to
30%, we estimate that we will need to enrol 4000 to
5000 preterm infants during the study period.
Ethical approvals
Safety of enrolled children in this trial will be ensured by
close monitoring and follow-up. All procedures except the
post-mortem examinations will be conducted following
the standard hospital protocols. A senior expert group led
by the site coordinator will meet weekly and monitor the
data and check study patients are managed according to
the national guidelines. The study proposal and the forms
will be reviewed and approved by institutional review
committees for all participating facilities prior to study
initiation.
Informed consent for enrolment to the study
All clinical procedures will be conducted per hospital
protocol and informed consent will be taken from care-
takers prior to their participation in the SIP project. An
informed consent form has been developed for care-
takers to read (or be read to them), and understand the
implications of the research and agree to sign before en-
rolment into the study.
Informed consent for post-mortem examinations
For preterm infants who die, parents or caretakers will be
asked to complete a separate consent for post-mortem ex-
aminations of the whole body or samples of relevant tissue
or fluids. The post-mortem examination could be a
complete diagnostic autopsy and/or MITS needle biopsy
depending on the consent of caretakers. Infant caretakers
will be read a detailed explanation for the post-mortem
examination and then be asked to sign if they agree, once
they have understood that the research clinician will do a
whole body post-mortem examination or a sample of tissue
for needle biopsy. Parents or caretakers are also allowed to
take the information sheet to discuss among family mem-
bers before they decide to consent to the post-mortem
examinations.
Monitoring
All preterm infants in the hospital NICU will be evalu-
ated at least twice daily by a nurse and document the
findings as per case report forms (CRFs). The site coord-
inator and the nursing coordinator will ensure that all
forms are complete, samples for laboratory are taken in
sufficient quantity and quality and the relevant lab, radi-
ology or pathology personnel made aware of the samples
sent.
The relevant clinical, laboratory, and autopsy data
will be made available for a panel of experts to re-
view every 6 months. The panel of experts will be
made up of neonatologists or paediatricians, microbi-
ologists, pathologists and epidemiologists both from
internal and external sources.
Follow up of surviving infants and determining final
cause of deaths
For those infants who are discharged alive, follow up will
be done weekly by phone and face to face meetings (at least
once) until the age of 28 days. If the preterm infant dies at
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home, the WHO verbal autopsy tool will be used in
addition to the hospital information to provide data to de-
termine the cause(s) of death.
A panel of experts will be formed to evaluate cause of
death. They will meet approximately every 6 months or
whenever there are approximately 100 deaths that need to
be evaluated for primary and contributory causes of death.
The panel will review clinical data, maternal risk factors,
microbiology and other related laboratory data, imaging
data, autopsy data and verbal autopsy data.
Prior to the first panel meeting, guidelines for assigning
the main and contributing cause of death will be distributed
to the panel members to help ensure consistency in deter-
mining the cause of death. However, the cause of death will
be based on the WHO categories and criteria for cause of
neonatal death.
At the end of each meeting of the panel of experts, the
results should be available for each case regarding clin-
ical diagnosis and the primary and contributing cause of
death by autopsy and in some cases verbal autopsy re-
sults. An analysis of the comparison of these results
would indicate the amount of agreement vs. disagree-
ment of the panel assignment with the autopsy, clinical
diagnosis, and verbal autopsy.
Data entry and data management
A senior bio-statistician will be responsible for the over-
all oversight of data management. The data management
system (DMS) will be developed by Addis Ababa Univer-
sity and used at each of the participating study sites as
described below.
Data entry and data collection and transmission
The database will be constructed using Structured Query
Language database. Code to check logic will be developed
and integrated with the database to minimize errors during
data entry. Internal validation checks such as skipping pat-
tern, ranges, value labels and consistence checks will be
programmed.
Data will be entered into computers using the DMS de-
veloped for this study. The DMS allows site staff to produce
project reports and scheduled backups of the study data-
base. Data entry clerks will be trained on the DMS system
and will maintain the central database for the study. The
data entry staff at each hospital site will be responsible for
entering data from all completed hard copy forms into the
DMS, which will be installed on the study computers. If
data corrections are needed, study staff will enter the cor-
rections into the DMS, which will create an automatic audit
trail for future. The DMS has built-in quality checks to ver-
ify the accuracy and quality of the data entered.
Electronic data will be transferred on a weekly basis
from each data management computer to the central
data centre at AAU, creating a complete data repository.
These records are uploaded on the central server and
then merged with the existing database to add new re-
cords and update edited records.
Monthly audits and incomplete data reports will be per-
formed by a review team consisting of at least the Site Co-
ordinator and Data Entry staff person. Data editing and
error resolution will be performed monthly. Additional
data review will be performed at each hospital by the
co-investigator.
Data security and confidentiality
Protecting the confidentiality and ensuring the security
of study data is a top priority. At the time of enrolment,
each participant is given a unique participant identifica-
tion number. All subsequent data collection will be
linked only to the identification number rather than par-
ticipant name.
Data analysis plan
The primary analysis will be a combined analysis across all
sites comparing proportions of causes of death among
those who died, among those who died and had autopsies
done and the proportion of similar diagnoses among those
who survived. Simple comparison of proportions by cat-
egories of diseases or conditions will be done among all re-
cruited cases against all preterm infants who were born in
the hospitals. The denominator will be those infants identi-
fied as having a preterm birth with gestational age con-
firmed by ultrasound, LMP or the New Ballard. Other
comparisons by diagnosis i.e. clinical versus autopsy, stand-
ard autopsy versus MITS, clinical diagnosis versus expert
panel diagnosis will be done. Sensitivity, specificity and
overall diagnostic accuracy of individual signs and combi-
nations of signs will be calculated against final diagnosis
among those who survived versus those who died. The lat-
ter will help develop clinical algorithms for common pre-
term diseases or conditions. The odds ratios of maternal
and obstetric variables against death will also be calculated.
Further comparisons of the above outcomes will be
made by gestational age (late preterm, moderate preterm
and extreme preterm and various birth weight groups as
well as maternal socio-economic, obstetric risk factors).
Supervision and quality control mechanisms
Visits to each site will be carried out regularly by the
Principal Investigator, the technical adviser and the clin-
ical coordinator to check data quality and provide sup-
port as necessary. Where necessary, experience sharing
will be arranged between sites so that the research cap-
acity of institutions with less research experience will be
strengthened.
The CRF (Table 1) were pretested at study hospitals
for 2 weeks prior to finalization. All study staff were ori-
ented to the CRFs as well as the manual of operations
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and procedures before the study was launched. The site
coordinators were trained to review completed CRFs.
The manual of operations and procedures and the CRF’s
were developed by local and external experts, based on the
national manual “Neonatal Intensive Care Unit Training-
Management Protocol” published by the Federal Ministry
of Health of Ethiopia in 2015. The manual consists of roles
and responsibilities, definitions, clinical presentations and
indications for investigations.
Discussion
This study aims to identify the common causes of illness
and death in preterm infants such that it is possible to de-
velop an approach on the clinical management of common
conditions or disease categories in preterm infants in low-
resource settings. The availability of such data could
facilitate the development of an integrated imple-
mentation package addressing these common condi-
tions such that a significant reduction in neonatal
mortality could be achieved. Designing an integrated
approach may accelerate scaling up interventions
within national programs addressing the major causes of
preterm mortality in low-resource settings. Global, re-
gional and national technical and implementing partners
and donors could prioritize the package of interventions
with potential maximum impact.
One of the challenges of this study will be to ensure that
the study subjects are truly preterm infants. Three methods
(LMP, ultrasound and New Ballard scores) will be applied
for assessment of gestational age. In the study, we expect a
small proportion of the infants to have ultrasound done
during the first trimester of the pregnancy and LMP may
not be reliable in all cases. However, the New Ballard will
be used in all infants before 7 days postnatal age. While
the national policy defines foetuses below 28 weeks of life
as abortions, in this study, we have decided to include any
infant born with signs of life or an Apgar score of 1 or
more regardless of gestational age. We have not limited
the minimum gestational age or weight of the preterm in-
fant for admission to the NICU’s if they are normally ad-
mitted. Only infants admitted to the hospital prior to
7 days postnatal age are eligible for enrolment in the study
because otherwise too little clinical information on the
course of the first 7 days of life will likely be available. The
research team will follow all infants admitted to the study
until death or to the age of 28 days.
The principal result of the study is determination of the
most common causes of mortality of preterm infants in a
low-resource setting. The challenge is obviously to clearly
define what a low resource setting neonatal care practice is.
What we have done is to ensure that the study clinicians
are knowledgeable on the diagnostic methods based on the
national guidelines but that we do not interfere in the man-
agement in the study NICU’s. At the completion of the
study and based on its results, we will make recommenda-
tions regarding the clinical protocols and investigations that
could be practiced in these low-resource settings. In the
study settings, measures such as early initiation and exclu-
sive breast feeding, keeping the baby warm, kangaroo
mother care, resuscitation for perinatal asphyxia, CPAP for
RDS, and antibiotics for sepsis are intended to be provided
as part of appropriate care in such settings. The extent to
which these interventions are appropriately provided will
be determined. Overall, this study should document which
conditions could be better treated to reduce neonatal mor-
tality associated with preterm birth.
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GA: Gestational age; IVH: Intraventricular haemorrhage; LMP: Last menstrual
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Table 1 Summary of SIP Case Report Forms
FORM Number and Name Purpose Who Completes
Form 00 – Screening Log To document population screened Research nurse/clinician
Form 01 – Eligibility Form To confirm eligibility Research nurse/clinician
Form 02 – Obstetric Form Maternal history and obstetric status Nurse/Obstetrician/pediatrician
Form 03A – Healthy Newborn Form To assess preterm infants discharged without NICU
admission
Nurse/pediatrician
Form 03B – NICU Admission/Clinical Form To assess preterm infants admitted to NICU Clinician/pediatrician
Form 04 – Study Monitoring Form To monitor infants in NICU Research nurse/clinician
Form 05 – Follow-up Form To monitor kids discharged before day 28 Research nurse/clinician
Form 06 – Final Diagnosis at Day 28 or death Clinical diagnosis at NICU discharge or death < 28 days Pediatrician
Form 07 – Verbal Autopsy Form (WHO) To document deaths which occur at home Research nurse/opted experts from Public
health
Form 08A – Complete Diagnostic autopsy To document detailed findings of additional
investigation
Pathologist
Form 08B – Minimally Invasive Tissue Sampling
(MITS)
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